The TallyHo Mouse as a model to study prostate hyperplasia during type 2 diabetes

Al Hinai H1, Lasri S1, Leando de St-Vil D1, Cammisotto P1, Campeau L1

Research Type

Pure and Applied Science / Translational

Abstract Category

Male Lower Urinary Tract Symptoms (LUTS) / Voiding Dysfunction

Abstract 227
Experimental therapeutics
Scientific Podium Short Oral Session 25
Friday 9th October 2026
10:15 - 10:22
Parallel Hall 4
0.10 Sydney
Capacity: 265
Benign Prostatic Hyperplasia (BPH) Basic Science Animal Study Male
1. Lady Davis Institute for Medical Research
Presenter
Links

Abstract

Hypothesis / aims of study
Benign prostatic hyperplasia (BPH) is a common condition developping with age. Hormonal changes, particularly those affecting androgens, are thought to be the main cause. Other factors like metabolic symdrome, obesity, diabetes or cardiac diseases, contribute to BPH. The Tally Ho (TH) mouse is an established polygenic model of type 2 diabetes, with sustained hyperglycemia and insulin resistance at a very early age (8 weeks). The present project examines the characteristics of the prostate tissue in aging TH mice compared to its non-diabetic counterparts, the SWR mice.
Study design, materials and methods
Prostate tissues from TallyHo and SWR mice were harvested at 10, 14 and 18 weeks of age. Body weight, glycemia and prostate mass were measured. Prostate histology was examined using Masson’s trichrome. Contractile characteristics were assessed using organ bath. Proteins were semi-quantified by immunoblotting and data confirmed by immunofluorescence. Gene expression was evaluated by RT-qPCR.
Results
At age 18 weeks, Th mice were hyperglycemic (glycemia > 30mM) while SWR were normoglycemic. However, prostate weight were significantly lower in TH than SWR. Nonetheless, histology reveals massive epithelial hyperplasia at 18 weeks in TH, with luminal narrowing, increased muscle area and similar amount of collagen compared to SWR of the same age. Prostate piece contraction under electric stimulation (EFS) or carbachol (cholinergic agonist) were stronger in TH. There was no differences in CTGF, fibronectin, PSA, SMAD7, TGF-β, or TNF-α mRNA expression between groups. On the other hand, immunoblotting revealed decreased junction protein (occludin, E-cadherin and ZO-1) levels in TH, while reduced BAX and increased Bcl-2 indicate a shift toward  pro-survival signaling. Surprinsingly, proteins involved in contraction (smoothelin and SMMHC-I) were decreased in TH while beta-actin was unaffected. Finally vimentin was increased but not cytokeratin 13. Immunofluorescence images confirmed the data obtained. No changes could be seen in inflammatory markers CD23, CD68 or TNF-α.
Interpretation of results
The TallyHo mouse develops epithelial prostatic hyperplasia, making it suitable to study structural changes happening during hyperglycemia. It does not mimick the inflammatory pattern of BPH, suggesting that androgens might rely on different pathways.
Concluding message
The tallyHo mice and SWR could constitute a valid model to study epithelial hyperplasia in the context of type 2 diabetes independently of changes in testosterone.
Disclosures
Funding Canadian Urologist Association Clinical Trial No Subjects Animal Species Mice Ethics Committee Canadian Committee for Animal Care AI Not at all
Citation

Continence 19S (2026) 102704
DOI: 10.1016/j.cont.2026.102704

01/11/2026 12:17:18